AdaptHealth (AHCO) Cash & Equivalents (2017 - 2026)

AdaptHealth's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $48.0 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 10.6% year-over-year to $48.0 million in Q1 2026; TTM through Mar 2026 was $48.0 million, a 10.6% decrease from a year earlier, with the FY2025 full-year figure at $106.1 million, down 3.29% from the prior year.
• Cash & Equivalents eased to $48.0 million in Q1 2026 per AHCO's latest filing, from $106.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $119.4 million in Q1 2022 and bottomed at $45.1 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $79.6 million (2024), against an average of $81.8 million.
• Across the five-year window, Cash & Equivalents tumbled 69.08% in 2022 and surged 78.44% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $46.3 million in 2022, then jumped by 66.69% to $77.1 million in 2023, then surged by 42.28% to $109.7 million in 2024, then dropped by 3.29% to $106.1 million in 2025, then plunged by 54.81% to $48.0 million in 2026.
• Per Business Quant, the three latest AHCO Cash & Equivalents figures stand at $48.0 million (Q1 2026), $106.1 million (Q4 2025), and $80.4 million (Q3 2025).